Concepedia

Petros Dimitriadis

PD

14

Publications

685

Citations

11

H-Index

2020

Active since

Affiliations

The Netherlands Cancer Institute(Current)

Oncode Institute

Melanoma Institute Australia

The University of Sydney

Royal North Shore Hospital

Petros Dimitriadis is an author at The Netherlands Cancer Institute specializing in immunology, immunotherapy, and medicine.

ORCID

Top concepts

Publications per year

2020–2024

14

Publications

14

Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma

Elisa A. Rozeman, Esmée P. Hoefsmit, Irene L. M. Reijers et al. · Nature Medicine · 2021 · 322 citations

, , +8

Comprehensive analysis of cutaneous and uveal melanoma liver metastases

Esmée P. Hoefsmit, Elisa A. Rozeman, Trieu My Van et al. · Journal for ImmunoTherapy of Cancer · 2020 · 70 citations · Full text

IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma

Irene L. M. Reijers, Disha Rao, Judith M. Versluis et al. · The Journal of Experimental Medicine · 2023 · 70 citations · Full text

, , +15

Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors

Paulien Kaptein, Célia Jacoberger-Foissac, Petros Dimitriadis et al. · Science Translational Medicine · 2022 · 50 citations · Full text

Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma

Itske Fraterman, Irene L. M. Reijers, Petros Dimitriadis et al. · Nature Medicine · 2023 · 40 citations · Full text

, , +7

Rows per page

1–5 of 14